HR 9886 · 118th Congress · Health

BUPE for Recovery Act

Introduced 2024-09-27· Sponsored by Rep. Tonko, Paul [D-NY-20]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.(2024-09-27)

Plain Language Summary

[AI summary unavailable — showing source text] [Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 9886 Introduced in House (IH)] <DOC> 118th CONGRESS 2d Session H. R. 9886 To require the Administrator of the Drug Enforcement Administration to temporarily exempt buprenorphine from the Suspicious Orders Report System for the remainder of the opioid public health emergency. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES September 27, 2024 Mr. Tonko introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To require the Administrator of the Drug Enforcement Administration to temporarily exempt buprenorphine from the Suspicious Orders Report System for the remainder of the opioid public health emergency. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assem…

Summarized by Claude AI · Non-partisan · For informational purposes only